| Price | 2.68 |
| Price Change Today | -$0.03 (-1.11%) |
| P&P rating | ![]() |
| Zacks Rank | 4 - SELL |
| Open Price | $2.76 |
| Previous Close | $2.71 |
| Daily Range | $2.67 - $2.79 |
| 52-Week Range | $1.50 - $2.88 |
| Volume | 1,309,910 |
| Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment